Portfolio Diversification
Range
Most Diversified
31 instruments
August 19, 2025
Least Diversified
0 instruments
February 1, 2022
Average
29.2 instruments
Most Consistent Holdings
Top 5
JNJ97.67%
MRK97.67%
PFE97.67%
AMGN97.67%
ABBV97.67%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since February 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Bridgebio (BBIO) | 4.08% | 6.37% | 76.22% | - |
 Eli Lilly (LLY) | 3.81% | 3.35% | 97.67% | - |
 Guardant Health (GH) | 3.73% | 10.28% | 97.67% | - |
 Vertex (VRTX) | 3.51% | 2.5% | 97.67% | - |
 Exact Sciences (EXAS) | 3.4% | 6.78% | 97.67% | - |
 Gilead Sciences (GILD) | 3.27% | 3.11% | 97.67% | - |
| Merck (MRK) | 3.23% | 2.57% | 97.67% | - |
| Johnson & Johnson (JNJ) | 3.22% | 2.93% | 97.67% | - |
| AbbVie (ABBV) | 3.15% | 2.86% | 97.67% | - |
| Amgen (AMGN) | 3.12% | 2.88% | 97.67% | - |
 Regeneron (REGN) | 3.12% | 2.36% | 97.37% | - |
 Bristol-Myers Squibb (BMY) | 2.97% | 2% | 97.45% | - |
 Illumina (ILMN) | 2.96% | 2.91% | 97.52% | - |
 ImmunoGen Inc (IMGN) | 2.92% | 0% | 49.96% | 2/14/2024 |
| Pfizer (PFE) | 2.88% | 2.3% | 97.67% | - |
 Exelixis (EXEL) | 2.64% | 4.94% | 71.7% | - |
 CRISPR Therapeutics (CRSP) | 2.54% | 0% | 72.87% | 12/26/2024 |
 Revolution Medicines (RVMD) | 2.51% | 4.59% | 76.22% | - |
 Argenx (ARGX) | 2.47% | 3.32% | 75.93% | - |
 Syndax (SNDX) | 2.22% | 3.2% | 76.22% | - |
 Blueprint Medicines (BPMC) | 2.22% | 0% | 66.67% | 7/23/2025 |
 Iovance (IOVA) | 2.17% | 0.79% | 76.15% | - |
 Arcellx (ACLX) | 1.83% | 2.4% | 50.84% | - |
 TG Therapeutics (TGTX) | 1.65% | 2.42% | 46.32% | - |
 AstraZeneca (AZN) | 1.61% | 2.94% | 50.84% | - |
 Mirati Therapeutics Inc (MRTX) | 1.48% | 0% | 48.94% | 1/31/2024 |
 SpringWorks Therapeutics (SWTX) | 1.41% | 0% | 39.82% | 7/3/2025 |
 Zai Lab (ZLAB) | 1.39% | 1.59% | 50.04% | - |
 BD (BDX) | 1.36% | 1.88% | 50.84% | - |
 BeiGene (ONC) | 1.29% | 0% | 46.83% | 1/2/2024 |
 Crinetics (CRNX) | 1.27% | 2.97% | 33.7% | - |
 Fate Therapeutics (FATE) | 1.16% | 0% | 46.83% | 1/2/2024 |
 Seagen Inc (SGEN) | 1.08% | 0% | 24.29% | 12/18/2023 |
 Merus (MRUS) | 0.95% | 4.84% | 24.8% | - |
 Halozyme (HALO) | 0.9% | 2.94% | 24.8% | - |
 Legend Biotech (LEGN) | 0.89% | 0% | 25.38% | 1/2/2024 |
 Incyte (INCY) | 0.88% | 0% | 21.44% | 1/12/2023 |
 BioNTech SE (BNTX) | 0.82% | 0% | 21.44% | 1/12/2023 |
 2Seventy Bio (TSVT) | 0.81% | 0% | 21.44% | 1/12/2023 |
 Option Care Health (OPCH) | 0.8% | 0% | 26.04% | 12/26/2024 |
 Scholar Rock (SRRK) | 0.78% | 3.02% | 24.8% | - |
 Rocket (RCKT) | 0.74% | 0% | 26.04% | 12/26/2024 |
 Arvinas (ARVN) | 0.73% | 0% | 26.04% | 12/26/2024 |
 Agenus (AGEN) | 0.72% | 0% | 21.44% | 1/12/2023 |
 LabCorp (LH) | 0.71% | 0% | 21.44% | 1/12/2023 |
 GlaxoSmithKline (GSK) | 0.67% | 0% | 21.44% | 1/12/2023 |
 MannKind (MNKD) | 0.66% | 0% | 25.38% | 1/2/2024 |
 Sorrento (SRNE) | 0.58% | 0% | 21.44% | 1/12/2023 |
 Celldex (CLDX) | 0.55% | 0% | 25.38% | 1/2/2024 |
 Inovio (INO) | 0.55% | 0% | 21.44% | 1/12/2023 |
 Clovis Oncology Inc (CLVSQ) | 0.49% | 0% | 19.99% | 12/22/2022 |
 Janux (JANX) | 0.44% | 0.79% | 24.8% | - |
 Surface Oncology Inc (SURF) | 0.36% | 0% | 19.99% | 12/22/2022 |
 Invitae Corp (NVTAQ) | 0.27% | 0% | 21.44% | 1/12/2023 |
 Curis (CRIS) | 0.25% | 0% | 19.99% | 12/22/2022 |
 Novocure (NVCR) | 0.18% | 1.92% | 7.59% | - |
 IDEAYA (IDYA) | 0.15% | 2.08% | 7.44% | - |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
| Instrument | Invested | Value |
|---|---|---|
| Exact Sciences (EXAS) | 6.26% | 5.15% |
| Illumina (ILMN) | 3.69% | 4.17% |
| Scholar Rock (SRRK) | 4.72% | 4.1% |
| Guardant Health (GH) | 5.47% | 4.06% |
| Iovance (IOVA) | 3.5% | 3.67% |
| Revolution Medicines (RVMD) | 2.45% | 3.54% |
| Eli Lilly (LLY) | 1.71% | 3.46% |
| Arcellx (ACLX) | 2.82% | 3.45% |
| Merck (MRK) | 3.47% | 3.42% |
| Janux (JANX) | 3.87% | 3.39% |
| Pfizer (PFE) | 4.88% | 3.27% |
| Bridgebio (BBIO) | 1.42% | 3.23% |
| Regeneron (REGN) | 3.22% | 3.2% |
| TG Therapeutics (TGTX) | 2.05% | 3.15% |
| Gilead Sciences (GILD) | 2.42% | 3.15% |
| SpringWorks Therapeutics (SWTX) | 3.48% | 3.09% |
| Blueprint Medicines (BPMC) | 2.02% | 3.05% |
| Argenx (ARGX) | 2.14% | 3.04% |
| Bristol-Myers Squibb (BMY) | 3.69% | 3.04% |
| AbbVie (ABBV) | 2.8% | 3.03% |
| BD (BDX) | 3.58% | 3.02% |
| Vertex (VRTX) | 1.98% | 3.01% |
| Halozyme (HALO) | 3.28% | 2.98% |
| Amgen (AMGN) | 3.03% | 2.98% |
| Syndax (SNDX) | 5.42% | 2.94% |
| AstraZeneca (AZN) | 3.33% | 2.91% |
| Merus (MRUS) | 3.26% | 2.9% |
| Zai Lab (ZLAB) | 3.28% | 2.89% |
| Johnson & Johnson (JNJ) | 3.51% | 2.84% |
| Exelixis (EXEL) | 2.1% | 2.82% |